Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Hoshino (Atami, Japan). Quantitative computed tomography assessment of airway dimensions by combining tiotropium and indacaterol in patients with COPD. Eur Respir J 2014; 44: Suppl. 58, 4668

Member's Comments

No comment yet.

Related content which might interest you: Effects of combining tiotropium and salmeterol/fluticasone propionate on airway dimensions in patients with COPD Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Evaluating cardiac safety of tiotropium in patients with COPD: Combined analysis of Holter-ECG data from four trials Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Evaluation method of airways for asthma patients using low dose HRCT images Source: International Congress 2016 – Asthma management Year: 2016 Efficacy of tiotropium and indacaterol alone or the combination on dynamic lung hyperinflation and exercise tolerance in COPD Source: International Congress 2014 – Asthma and COPD management Year: 2014 Comparison of emphysema in patients with COPD before and after treatment of tiotropium by quantitative assessment by HRCT Source: Eur Respir J 2007; 30: Suppl. 51, 619s Year: 2007 The combination therapy with inhaled tiotropium bromide and indacaterol in COPD improves the peripheral airway function in static and dynamic status Source: International Congress 2014 – Asthma and COPD management Year: 2014 Comparison of EBUS and HRCT in assessment of airway wall in asthma and COPD Source: International Congress 2016 – From microimaging to functional evaluation of the lung Year: 2016 Exacerbator subtypes in the tiotropium safety and performance in respimat (TIOSPIR™) trial Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Late Breaking Abstract - Influence of omalizumab therapy on airway remodelling assessed with high-resolution computed tomography (HRCT) in severe allergic asthma patients Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018 Air-trapping on HRCT as a marker for patient outcome in severe asthmatics treated with azithromycin Source: International Congress 2014 – Different modalities and techniques for lung imaging Year: 2014 Computed tomography for evaluation of the small airway disease in asthma Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment Year: 2015 Free triple combination of glycopyrronium, indacaterol and ICS improves lung function and dyspnoea versus free double combination of indacaterol and ICS in patients with COPD: A post-hoc analysis from the GLOW6 study Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Comparison of indacaterol with tiotropium or once-daily dual long-acting bronchodilator therapy with roflumilast for severe COPD Source: International Congress 2014 – Markers Year: 2014 Mixed treatment analysis comparing tiotropium HandiHaler® and Respimat® Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Once-daily QVA149 improves lung function and dyspnoea compared with tiotropium plus formoterol: The QUANTIFY study Source: International Congress 2014 – Asthma and COPD management Year: 2014 Associations between quantitative CT measures and airway inflammation in COPD Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked Year: 2013 Once-daily tiotropium Respimat add-on to at least ICS in adult patients with symptomatic asthma: Pooled safety analysis Source: International Congress 2014 – Asthma and COPD management Year: 2014 Airway wall volume: Implications for the CT characterization of airway disease in smokers Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked Year: 2013 Lung function improvements with twice-daily aclidinium/formoterol fixed-dose combination in two 24-week studies in patients with COPD Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 QVA149 improves dyspnoea and lung function versus tiotropium in symptomatic patients using LABA/ICS preceding study enrolment: The BLAZE study Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014